Views & Analysis 2021 market access prospects for France In the latest of a suite of features looking at the biggest markets in Europe, Leela Barham takes stock of what 2021 could bring
News AZ COVID jab efficacy debate is hindering EU’s vaccine drive The spat between the EU and AstraZeneca over access to the company’s COVID-19 shot led to scathing remarks about its efficacy that now threaten to undermine the EU’s vaccination targets.
Views & Analysis How does HTA for orphan drugs differ across Europe? New research looks at the factors that speed up and slow down HTA appraisals for rare disease medicines across Europe.
News Sanofi pledges €10m to Notre Dame, but faces backlash Sanofi has said that it will donate 10 million Euros to the rebuilding of Notre Dame cathedral in Paris, prompting a mixed response from the public.
Views & Analysis Macron’s France: advancing towards a European vision for hea... What will Macron's government mean for healthcare in his country and Europe?
News BioMarin starts rebuilding after its downsizing spree BioMarin has made its first M&A play under James Sabry, buying Inozyme to flesh out its enzyme replacement therapies (ERTs) for rare diseases.
Market Access Sponsored Bridging research and clinical guidelines – interactive stra... Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.
